The global therapeutic vaccines market, valued at USD 6.7 billion in 2025, is projected to reach USD 11.0 billion in 2026 and USD 86.8 billion by 2035, representing a CAGR of 25.8% during the forecast period 2026 to 2035. In terms of type of vaccine, the peptide vaccines segment holds the highest share (close to 45%) of the current market. Over the last few years, this segment of the industry has witnessed substantial partnership activity and investment from various private and public sector inv...

The global voluntary carbon credit market, valued at USD 1.6 billion in 2025, is projected to grow to USD 2.6 billion in 2026 and USD 47.5 billion by 2035, representing a CAGR of 38% during the forecast period 2026 to 2035. Based on the application area, the industrial sector captures the largest (around 35%) share of the market, and this trend is unlikely to change. In May 2026, the Singapore government and the World Bank Group jointly launched the Singapore Carbon Markets Program at the Innova...

The chromatography market, valued at USD 12.05 billion in 2025, is projected to reach USD 12.65 billion in 2026 and USD 22.35 billion by 2035, with a 6.53% CAGR during the forecast period 2026 to 2035. In September 2025, Testa Analytical entered into an agreement with Mazet & Co to expand the access of their flow measurement technologies across French-speaking regions of Europe and North Africa. The collaboration aims to enhance customer support in these markets and underscore the commitment of...

The global agricultural biologicals market, valued at USD 16.62 billion in 2025, is projected to reach USD 18.27 billion in 2026 and USD 43.53 billion by 2035, representing a CAGR of 10.1% during the forecast period 2026 to 2035. In May 2026, IPL Biologicals opened its third manufacturing plant in Vadodara, Gujarat, raising its annual production capacity to 7,000 KL/year to strengthen its supply chain capabilities and meet the growing demand for these biologicals in India and export markets. In...

The global chromatography consumables market, valued at USD 5.6 billion in 2025, is projected to reach USD 6.0 billion in 2026 and USD 9.7 billion by 2035, representing a CAGR of 5.6% during the forecast period 2026 to 2035. In terms of product, columns hold the highest (around 45%) share of the current market. With respect to chromatography technique, liquid chromatography dominates the current market. In April 2026, Merck completed the acquisition of JSR Life Sciences’ chromatography busines...

The global drug reconstitution systems market, valued at USD 5.4 billion in 2025, is projected to reach USD 5.9 billion in 2026 and USD 10.8 billion by 2035, representing a CAGR of 7.0% during the forecast period 2026 to 2035. In terms of type of reconstitution system, cartridges hold the highest share (close to 50%) of the current market. Based on fabrication material, the glass segment holds the largest share of the current market.

The global squamous non-small cell lung cancer market, valued at USD 9.3 billion in 2025, is projected to reach USD 10.0 billion in 2026 and USD 18.3 billion by 2035, representing a CAGR of 7.9% during the forecast period 2026 to 2035. In terms of therapeutic type, the immunotherapies segment holds the highest share (more than 35%) of the current market. In the absence of suitable targeted therapies, immunotherapy with or without chemotherapy has become the cornerstone of squamous NSCLC treatmen...

The GLP-1 receptor agonist market size, valued at USD 78 billion in 2025, is projected to reach USD 101.4 billion in 2026 and USD 180 billion by 2035, representing a CAGR of 6.6% during the forecast period 2026 to 2035. In recent years, there has been a notable shift in consumer lifestyles driven by the growing influence of social media, celebrity endorsements and direct-to-consumer advertising. This has led to a surge in the demand for weight loss and type 2 diabetes treatment solutions, which...

The next generation drug conjugates market, valued at USD 8.0 billion in 2025, is projected to reach USD 11.2 billion in 2026 and USD 26.2 billion by 2035, representing a CAGR of 9.9% during the forecast period 2026 to 2035. In terms of type of drug conjugate, ligand mediated RNAi conjugates hold the highest share (around 55%) of the current market. With respect to type of targeting ligand, next generation drug conjugates with amino sugar dominate (more than 60%) the current market.

The global teleradiology services market, valued at USD 9.2 billion in 2025, is projected to reach USD 10.1 billion in 2026 and USD 23.3 billion by 2035, representing a CAGR of 9.7% during the forecast period 2026 to 2035. In terms of imaging modality, CT scan accounted for 35% of market revenues in 2026.With respect to end user, hospitals (51%) dominate the current market.

The global anti-aging drugs for dogs market, valued at USD 0.09 billion in 2026, is projected to reach USD 6.16 billion by 2040, with a 36% CAGR during the forecast period 2026 to 2040. Over the years, the pet dog population has increased at a substantial rate. According to the American Veterinary Medical Association, the dog population has steadily increased from 52.9 million in 1996 to 89.7 million in 2024. Also, the number of pet-owning households has increased from 31.3 million in 1996 to 59...

The global anti-obesity drugs market, valued at USD 28.2 billion in 2025, is projected to reach USD 45.1 billion in 2026 and USD 106.5 billion by 2035, representing a CAGR of 10.0% during the forecast period 2026 to 2035. In terms of route of administration, parenteral route captures the highest share of the current market.Based on the distribution channel, retail and online pharmacies are likely to capture the highest share of the current market. In terms of key geographical regions, North Amer...

The global non-small cell lung cancer market size is estimated to grow from USD 23.8 billion in 2025 to USD 26.4 billion in 2026 and USD 56.0 billion by 2035, representing a CAGR of 8.7% during the forecast period. It is worth highlighting that among all the forms of non-small cell lung cancer, squamous cell carcinoma is one of the most common types and it may develop due to prolonged use of tobacco. In fact, the World Health Organization report shows that smoking is the main cause of lung cance...

The global female sexual dysfunction market reached USD 0.61 billion in 2026 and is projected to reach USD 2.87 billion by 2040, growing at a CAGR of 11.7% over the forecast period 2026 to 2040, driven by broader treatment eligibility and delivery innovation. Treatment demand is shifting from menopause-centered symptom management toward broader desire, arousal, pain, and orgasm-focused care. Estrogen therapy still leads drug demand with 41.0% share in 2026, while oral therapies hold 58.0% across...

The global medication adherence market, valued at USD 5.45 billion in 2025, is projected to reach USD 6.08 billion in 2026 and USD 15.35 billion by 2035, representing a CAGR of 10.92% during the forecast period 2026 to 2035. In May 2026, Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, announced its participation at the BofA Securities 2026 Healthcare Conference. In January 2026, MIT engineers developed ingestible pills equipped with biod...

The global infusion pumps market size is valued at USD 13.90 billion in 2025 and projected to grow from USD 14.87 billion 2026 to USD 25.39 billion in 2035, representing a CAGR of 6.1% during the forecast period 2026 to 2035. In terms of device type, volumetric pumps currently hold the largest share (30%) due to their high precision, safety, versatility, and broad applications in healthcare (including blood infusion, drug administration, fluid transmission during surgeries, nutrient delivery). A...

The global stroke AI market is expected to rise from USD 0.44 billion in 2026 to reach USD 8.05 billion by 2040, growing at a CAGR of 23.1% over the forecast period 2026 to 2040, driven by time-critical stroke detection, care-team activation, and automated treatment-routing workflows. Based on offering, AI imaging and triage software captures 47.0% market share in 2026, whereas analytics and performance-management services register a 28.4% CAGR through 2040, driven by outcomes tracking. Based on...

The global GLP-1 manufacturing market is expected to rise from USD 14.6 billion in 2026 to reach USD 88.5 billion by 2040, growing at a CAGR of 13.7% over the forecast period 2026 to 2040, driven by chronic obesity and cardiometabolic demand. Based on manufacturing stage, drug substance / peptide API synthesis captures 35.0% market share in 2026, whereas device assembly and secondary packaging registers a 16.5% CAGR through 2040, driven by pen and combination-product scale-up. Based on manufactu...

The small molecule API manufacturing market, valued at USD 197 billion in 2025, is projected to reach USD 204 billion in 2026 and USD 266 billion by 2035, representing a CAGR of 3.0% during the forecast period 2026 to 2035. In terms of type of manufacturers, the in-house manufacturers are likely to secure ~65% of the overall revenue share in 2026, due to the growing preference towards large, vertically integrated pharmaceutical companies. In March 2026, Cambrex announced the initial completion o...

The global cell encapsulation market, valued at USD 5.0 billion in 2025, is projected to reach USD 5.7 billion in 2026 and USD 15.8 billion by 2035, representing a CAGR of 12.0% during the forecast period 2026 to 2035. In April 2026, Atelerix signed a strategic partnership agreement with JH Health to expand the distribution and use of its proprietary non-cryogenic hydrogel encapsulation and cell preservation technology in the Middle East. In March 2026, researchers at MIT published findings on a...